Alterity Therapeutics - ADR Peer Comparison

$4.67

$-0.11 (-2.30%)

As on 27-Aug-2026 12:30EDT

Market cap

$85 Mln

Revenue (TTM)

$6 Mln

P/E Ratio

--

P/B Ratio

2.2

Div. Yield

0 %

Edit

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
Market cap ($ Mln)	85	153	9
Revenue (A$ Mln)	5	0	7
Net Profit (A$ Mln)	-12.15	-20.70	-5.22
Net Margin (%)	-531.34	-2,284,277.09	-71.92
RoE (%)	-43.23	226.03	-50.30
Price to Earnings	--	--	--
Price-To-Book	2.19	4.63	1.03

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (A$ Mln)

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
Operating Revenue	5.44	0.04	7.29
Cost of Revenue	0.13	--	2.52
Gross Profit	5.31	0.04	4.77
Operating Expenses	19.89	14.26	10.11
Operating Profit (EBIT)	-14.57	-14.22	-5.34
Other Income	--	--	--
Profit before Tax	-12.08	-22.45	-5.22
Provision for Tax	0.07	-1.75	--
Profit after Tax (Net Income)	-12.15	-20.70	-5.22
Minority Interest	--	--	--
Consolidated Profit	--	--	--

Liabilities (A$ Mln)

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
Shareholder's Funds	42.40	-8.30	8.03
Minority Interest	--	--	--
Non-Current Liabilities	0.09	0.31	0.09
Current Liabilities	3.53	14.05	1.97
Total Liabilities	46.03	6.06	10.09

Assets (A$ Mln)

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
Non-Current Assets	0.16	1.13	0.11
Current Assets	45.87	4.93	9.98
Total Assets	46.03	6.06	10.09
Total Debt*	0.16	0.40	0.12
Net Current Assets	42.34	-9.12	8.05

Cashflow (A$ Mln)

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
Cash From Operating Activities	-11.45	-13.28	-6.14
Cash Flow from Investing Activities	-7.50	--	-2.90
Cash from Financing Activities	39.67	15.98	0.20
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
ROCE (%)	-42.99	239.50	-49.60
ROE (%)	-43.23	226.03	-50.30
ROA (%)	-37.23	-149.76	-40.68
EBIT Margin (%)	--	--	--
Net Margin (%)	-223.35	-49,290.48	-71.58
Cash Profit Margin (%)	--	--	--

Growth Ratios

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
Revenue Growth (%)	0.35	-0.98	0.49
EBIT Growth (%)	--	--	--
Net Profit Growth (%)	36.48	22.69	24.81
EPS Growth (%)	0.46	0.56	0.27
Book Value Growth (%)	--	--	--

Valuation Ratios

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
Price / Earnings	-4.20	-0.26	-1.95
Price / Book Value	1.20	-0.64	1.27
Dividend Yield (%)	--	--	--
EV/EBITDA	-0.72	-0.10	-0.84
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
Debt to Equity	0.00	-0.05	0.01
Short term debt to equity ratio	0.00	-0.05	0.01
Current Ratio	12.98	0.35	5.07
Quick Ratio	--	--	4.17
Interest Coverage	--	--	-733.30

Operating Efficiency Ratios

	Alterity Therapeutics - ADR	Kazia Therapeutics - ADR	Immuron - ADR (IMRN)
Debtors to sales (%)	72.40	214.29	10.86
Asset Turnover	0.17	0.00	0.57
Receivable days	267.92	969.65	54.61
Inventory Days	-64.13	--	243.10
Payable days	1,603.11	--	157.74
Cash Conversion Cycle	-1,399.31	--	139.96

Annual
Quarterly